http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2495663-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d67822fb73e7f0f963281e4c5bc3854 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-231 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194 |
| filingDate | 2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a9df4ff17bf1c20c253664d728caa13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b826c02936d21f53f86425d9ac10784 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f783737ac665a407e7ffa5d7ea8e8ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a024f772329dff679d0bd0c38fe406a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c984d7a6e9e9fc25fb89a70d197d9503 |
| publicationDate | 2013-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2495663-C1 |
| titleOfInvention | Solid dosage form of taurine with improved pharmacological properties |
| abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to medicine and pharmacology, and concerns solid dosage forms of taurine. The dosage forms are applicable in treating type I and II diabetes mellitus, cardiovascular insufficiency and hepatobilliary systems. The dosage forms of taurine contain pharmaceutically acceptable carriers, excipients and additives differing by the fact that such forms have an external coating; as taurine promotors, they contain potassium chloride and N-vinylpyrrolidone copolymer. n EFFECT: solid dosage forms possess the improved pharmacological properties and improved efficacy in cardiovascular insufficiency, diabetes mellitus and hepatobilliary systems. n 5 cl, 6 tbl, 6 ex |
| priorityDate | 2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.